The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Action Alert: Protect Access to Compounded Peptides Federal regulators are making decisions right now that could determine the future of peptide based therapies in the U.S. Compounded peptides such as BPC 157 and epitalon BPC 157: Miracle Healing Peptide or Hidden Danger? FDA to weigh easing limits on unproven peptides FDA Moves to Reevaluate Several Peptides American Med Spa Association